Acute Otitis Media — Why "Always Prescribe Antibiotics" Is No Longer the Standard

Lead

"Ear infection means antibiotics" — this near-universal assumption changed significantly after the American Academy of Pediatrics (AAP) revised its clinical practice guideline in 2013 [1]. The update formally incorporated "watchful waiting" as a recommended option in defined circumstances, establishing that immediate antibiotic treatment is not always required. Japan's clinical practice guideline, revised in 2018, reflects the same shift [5]. Why did the guidance change, and what does it mean in practice?

How Common Is Acute Otitis Media, and What Causes It?

Acute otitis media is one of the most common bacterial infections in young children. In a prospective Boston cohort from the 1970s–80s, 83% of children had had at least one episode by age three [6]; in a US cohort followed after pneumococcal conjugate vaccines were introduced, the figure was still about 60% [7]. The usual mechanism is bacteria that colonize the nasopharynx (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) reaching the middle ear through the Eustachian tube following a viral respiratory infection. A proportion of cases are caused by virus alone.

Known risk factors include daycare attendance, passive smoke exposure, and feeding an infant with a bottle while lying flat [1]. The widespread adoption of the pneumococcal conjugate vaccines (PCV) has reduced the incidence of pneumococcal otitis media.

What Is Watchful Waiting?

The central message of the 2013 AAP guideline is that not every case of acute otitis media requires immediate antibiotics [1].

Immediate antibiotic treatment is recommended when:

• The child is 6 months to under 2 years and both ears are affected
• The eardrum has ruptured and fluid is draining from the ear
• The illness is severe: moderate or severe ear pain, ear pain lasting 48 hours or more, or fever of 39°C (102.2°F) or higher

Watchful waiting (48–72 hours of observation) is an option when:

• The child is 6 months to under 2 years, with one ear affected and mild symptoms (mild ear pain for less than 48 hours, temperature below 39°C)
• The child is 2 years or older, with one or both ears affected but mild symptoms

When watchful waiting is chosen, antibiotics are started if symptoms worsen or do not improve within 48–72 hours. This approach assumes the parent and clinician have discussed and agreed on the plan. Infants younger than 6 months fall outside the AAP guideline, and watchful waiting is not among its options for them.

So how many children get better without antibiotics? Pooled analyses of older randomized trials found a generally favorable course in control groups, with an NNT for antibiotics of 8–16 [1]. The two 2011 trials that used strict diagnostic criteria (in children younger than 2–3 years) found that about half improved on placebo, but that antibiotics helped more than earlier estimates suggested (NNT 3–4) [1,2,3]. The current picture: most mild cases settle on their own, and the added benefit of antibiotics is largest in younger children with a clear-cut diagnosis.

When Antibiotics Are Indicated

Amoxicillin is the first-choice antibiotic when treatment is indicated. To cover resistant pneumococci, the AAP guideline recommends high-dose amoxicillin (80–90 mg/kg/day) [1]. Duration of treatment is generally five to ten days depending on severity and age.

A Finnish placebo-controlled randomized trial (Tähtinen 2011, children aged 6–35 months) found treatment failure in 18.6% of the antibiotic group versus 44.9% of the placebo group — a number needed to treat (NNT) of about 4 to prevent one treatment failure [1,2]. Pooled analyses of older trials put the NNT for pain or fever at 8, rising to around 15 for one-sided infection in children aged 2 and over [1]. Neither figure is negligible; both describe real, meaningful efficacy in the right clinical context. The same Finnish trial also found diarrhea in 47.8% of the antibiotic group versus 26.6% of the placebo group — about 1.8 times as often [2]. It is this balance that informs the watchful-waiting approach for milder cases.

Resistance and Recurrent Otitis Media

The increase in penicillin-resistant S. pneumoniae (PRSP) is a concern in many countries and is the reason high-dose amoxicillin is preferred. If this fails, amoxicillin-clavulanate is a next-line option.

Children who experience three or more episodes within six months, or four or more within a year (with at least one in the past six months), and who still have fluid in the middle ear when assessed, may be candidates for tympanostomy tube insertion [1,4]. This surgical procedure maintains ventilation of the middle ear and reduces recurrence frequency.

Translating Evidence into Everyday Decisions

• Even when a child is clearly in ear pain, knowing that "48 hours of watchful waiting" is a legitimate option — depending on age and severity — can reduce unnecessary antibiotic use
• When antibiotics are prescribed, completing the full course (five to ten days) matters for resistance prevention
• Recording fever level, pain intensity, changes in feeding or appetite, and the date symptoms began helps the clinician and parent assess progress together
• If symptoms worsen or fail to improve after 48–72 hours of watchful waiting, return for evaluation

Summary

The management of acute otitis media has moved from "ear infection equals antibiotics" to "a decision shaped by the specifics." The shift is grounded in evidence that many mild cases resolve without treatment and in concern about antibiotic side effects and rising resistance. Watchful waiting is not "doing nothing" — it is an active, structured period of observation with a clear plan for escalation, agreed upon between the clinician and the family.

References

1. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964–e999. doi:10.1542/peds.2012-3488. PMID: 23439909.
2. Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116–126. doi:10.1056/NEJMoa1007174. PMID: 21226577.
3. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105–115. doi:10.1056/NEJMoa0912254. PMID: 21226576.
4. Rosenfeld RM, Schwartz SR, Pynnonen MA, et al. Clinical practice guideline: tympanostomy tubes in children. Otolaryngol Head Neck Surg. 2013;149(1 Suppl):S1–S35. doi:10.1177/0194599813487302. PMID: 23818543.
5. Japanese Society of Otology; Japanese Society for Pediatric Ear, Nose and Throat; Japan Society for Infection and Aerosol in Otorhinolaryngology, eds. Clinical Practice Guideline for Pediatric Acute Otitis Media, 2018 edition. Tokyo: Kanehara Shuppan; 2018.
6. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83–94. doi:10.1093/infdis/160.1.83. PMID: 2732519.
7. Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics. 2017;140(3):e20170181. doi:10.1542/peds.2017-0181. PMID: 28784702.